Zars Pharma Inc. Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Salt Lake City UT United States (1996)
Status: Acquired by Nuvo Research Inc. (2011)

Organization Overview

First Clinical Trial
2004
NCT00108771
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ZARS Pharma | ZARS Pharma Inc.

Active Ingredients

Drugs in Phase 4 Trials (3)

ethyl chloride (1 trial)

lidocaine (xylocaine) (17 trials)

tetracaine (pontocaine) (17 trials)

Drugs in Phase 3 Trials (2)

fentanyl (Innovar) (4 trials)

ketoprofen (orudis) (3 trials)

Drugs in Phase 2 Trials (1)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breakthrough Pain (Phase 2)

Cancer Pain (Phase 3)

Carpal Tunnel Syndrome (Phase 2)

Chronic Pain (Phase 3)

Dermatitis (Phase 2)

Fibromyalgia (Phase 2)

Hand Dermatoses (Phase 2)

Myofascial Pain Syndromes (Phase 2)

Neuralgia (Phase 2)

Neuralgia, Postherpetic (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Rotator Cuff Injuries (Phase 2)

Shoulder Impingement Syndrome (Phase 2)

Skin Diseases (Phase 2)

Syndrome (Phase 2)

Tendinopathy (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 25
  • # of Trial APIs: 6